Skip to main content Skip to search Skip to main navigation
Flask High Quality Molecules
Truck Fast Delivery
Award Trusted by Researchers
Follow us: LinkedIn Contact Security

Alcohol

  • High-purity Alcohol
  • Extensive range of Alcohol
  • Ideal for drug discovery applications and organic synthesis
  • Fast delivery and expert support
Alcohol compounds are essential building blocks in pharmaceutical research. Our carefully curated selection offers diverse structures for SAR studies and lead optimization, ensuring quality and reliability for your projects.

Understanding Alcohol in Modern Chemistry

Explore the critical role of Alcohol in pharmaceutical development, medicinal chemistry research and organic chemistry.

Precision Chemistry

Precision Chemistry

Advanced synthesis techniques for superior quality compounds

Great Molecules for Chemical Diversity

Our catalogue of building blocks contains a diverse range of highly functionalised and decorated compounds. The 20 years of experience in supplying cutting-edge building blocks have given us the expertise to bring you the most exciting chemical motifs, adding chemical diversity to your projects.

Our diverse catalogue is tailored for medicinal chemistry, small molecule drug discovery and organic synthesis. Our unique range of Alcohol adds value to any research project.

We constantly add to our catalogue; the latest additions include a range of new Alcohol. We continue to bring you the latest and most exciting chemical compounds.

Quality Assurance

Quality Assurance

Every Alcohol product in our portfolio undergoes rigorous quality control testing. Our building blocks are supplied with the highest purity standards. We provide complete analytical characterisation, including:

  • ¹H and ¹³C NMR spectroscopy for structural verification
  • HPLC chromatograms confirming purity levels
  • Certificate of Analysis available.
  • Standard purity of 95%
  • Specific purity available upon request.

Diverse Applications

Diverse Applications

From oncology to neuroscience, enabling next-generation therapeutics

Over 26000 Alcohol in our catalogue
Found in over 400 FDA-approved drugs
95% of compounds available from stock

Alcohol products in our portfolio

The hydroxyl group is among the most prevalent functional groups in small-molecule drug discovery, present across a broad range of approved therapeutics and natural products. Its capacity to engage in hydrogen bonding, both as a donor and acceptor, makes it a versatile pharmacophoric element, contributing to target binding through direct interactions with residues in enzyme active sites and receptor binding pockets. Primary, secondary, and tertiary alcohols, along with their aromatic counterparts, phenols, each carry distinct electronic and steric profiles that influence potency, selectivity, and ADMET properties. Phenols, in particular, are widely exploited for their increased acidity and propensity to form strong hydrogen bonds with polar binding site residues.

Emerging synthetic techniques are exploiting the hydroxyl group in increasingly creative ways. In photochemistry, radical deoxyfunctionalisation strategies using visible-light photocatalysis enable C–O bond cleavage to form C–C and C–heteroatom bonds from readily available alcohol starting materials.

 Electrochemically, TEMPO-mediated anodic oxidation of primary and secondary alcohols to aldehydes, ketones, and carboxylic acids has gained significant traction as a practical and sustainable alternative to stoichiometric chemical oxidants, with demonstrated compatibility with sensitive substrates including propargylic and alpha-trifluoromethyl systems. 

The hydroxyl group appears frequently in FDA-approved drugs across multiple therapeutic areas. Atorvastatin (Lipitor, Pfizer), the widely prescribed HMG-CoA reductase inhibitor for hypercholesterolaemia, contains two secondary hydroxyl groups critical to its binding interaction with the target enzyme. More recently, Elacestrant (Orserdu, Stemline Therapeutics/Menarini), the first oral selective estrogen receptor degrader (SERD), received FDA approval in January 2023 for ESR1-mutated, ER-positive, HER2-negative advanced or metastatic breast cancer. The molecule incorporates a phenolic hydroxyl group within its tetrahydronaphthalene scaffold, contributing to its high-affinity estrogen receptor binding.

In organic synthesis, the hydroxyl group is central to a number of key named reactions.The Mitsunobu reaction enables stereospecific substitution of an alcohol with inversion of configuration, facilitating access to either enantiomer from a single alcohol precursor. Oxidation of primary and secondary alcohols using Swern conditions or Dess–Martin periodinane is a routine route to aldehydes and ketones, while the Barton–McCombie reaction provides deoxygenation via radical intermediates from secondary alcohols activated as xanthate esters.

Frequently Asked Questions

Common questions about our Alcohol products.

The hydroxyl group is among the most prevalent functional groups in small-molecule drug discovery, present across a broad range of approved therapeutics and natural products. Its capacity to engage in hydrogen bonding, both as a donor and acceptor, makes it a versatile pharmacophoric element, contributing to target binding through direct interactions with residues in enzyme active sites and receptor binding pockets.

Primary, secondary, and tertiary alcohols, along with their aromatic counterparts, phenols, each carry distinct electronic and steric profiles that influence potency, selectivity, and ADMET properties. Phenols in particular are widely exploited for their increased acidity and propensity to form strong hydrogen bonds with polar binding site residues, distinguishing their pharmacological behaviour from aliphatic alcohols.
Emerging synthetic techniques are exploiting the hydroxyl group in increasingly creative ways. In photochemistry, radical deoxyfunctionalisation strategies using visible-light photocatalysis enable C-O bond cleavage to form C-C and C-heteroatom bonds from readily available alcohol starting materials. Electrochemically, TEMPO-mediated anodic oxidation of primary and secondary alcohols to aldehydes, ketones, and carboxylic acids has gained significant traction as a practical and sustainable alternative to stoichiometric chemical oxidants.
Atorvastatin (Lipitor, Pfizer), the widely prescribed HMG-CoA reductase inhibitor for hypercholesterolaemia, contains two secondary hydroxyl groups critical to its binding interaction with the target enzyme. These hydroxyl groups participate directly in the hydrogen bonding network required for high-affinity engagement with HMG-CoA reductase, illustrating how a simple functional group can be essential to a drug's binding mode.
Elacestrant (Orserdu, Stemline Therapeutics/Menarini), the first oral selective estrogen receptor degrader, received FDA approval in January 2023 for ESR1-mutated, ER-positive, HER2-negative advanced or metastatic breast cancer. The molecule incorporates a phenolic hydroxyl group within its tetrahydronaphthalene scaffold, contributing to its high-affinity estrogen receptor binding.
Several key named reactions are central to hydroxyl group chemistry. The Mitsunobu reaction enables stereospecific substitution of an alcohol with inversion of configuration, facilitating access to either enantiomer from a single alcohol precursor. Oxidation of primary and secondary alcohols using Swern conditions or Dess-Martin periodinane is a routine route to aldehydes and ketones, while the Barton-McCombie reaction provides deoxygenation via radical intermediates from secondary alcohols activated as xanthate esters.

Still have questions?

Our technical support team is here to help with any inquiries about our Alcohol products.